Literature DB >> 30091648

How would we combat menopause as an Alzheimer's risk factor?

Lisa Mosconi1,2, Roberta Diaz Brinton3.   

Abstract

Entities:  

Keywords:  Alzheimer’s disease; Perimenopause; brain imaging; cognitive aging; early detection; magnetic resonance imaging; menopause; positron emission tomography; women

Year:  2018        PMID： 30091648      PMCID： PMC6296216          DOI： 10.1080/14737175.2018.1510320

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  14 in total

Review 1.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

2.  Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.

Authors:  Gerson Hernandez; Liqin Zhao; Adrian A Franke; Yu-Ling Chen; Wendy J Mack; Roberta D Brinton; Lon S Schneider
Journal:  Menopause       Date:  2018-02       Impact factor: 2.953

3.  Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.

Authors:  Howard N Hodis; Wendy J Mack; Donna Shoupe; Stanley P Azen; Frank Z Stanczyk; Juliana Hwang-Levine; Matthew J Budoff; Victor W Henderson
Journal:  Menopause       Date:  2015-04       Impact factor: 2.953

4.  Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.

Authors:  Roksana Karim; Melissa Koc; Jamaica R Rettberg; Howard N Hodis; Victor W Henderson; Jan A St John; Hooman Allayee; Roberta D Brinton; Wendy J Mack
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

5.  Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition.

Authors:  P M Maki; S M Resnick
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

Review 6.  Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.

Authors:  Heather M Snyder; Sanjay Asthana; Lisa Bain; Roberta Brinton; Suzanne Craft; Dena B Dubal; Mark A Espeland; Margaret Gatz; Michelle M Mielke; Jacob Raber; Peter R Rapp; Kristine Yaffe; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2016-09-27       Impact factor: 21.566

7.  2016 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2016-04       Impact factor: 21.566

Review 8.  Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Authors:  Pauline M Maki
Journal:  Menopause       Date:  2013-06       Impact factor: 2.953

9.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

10.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.

Authors:  Lisa Mosconi; Valentina Berti; Crystal Quinn; Pauline McHugh; Gabriella Petrongolo; Ricardo S Osorio; Christopher Connaughty; Alberto Pupi; Shankar Vallabhajosula; Richard S Isaacson; Mony J de Leon; Russell H Swerdlow; Roberta Diaz Brinton
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240
View more
  1 in total

Review 1.  A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment.

Authors:  Aarti Mishra; Yiwei Wang; Fei Yin; Francesca Vitali; Kathleen E Rodgers; Maira Soto; Lisa Mosconi; Tian Wang; Roberta D Brinton
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.